ETHOCUPS

Serial Number 98204247
730

Registration Progress

Application Filed
Sep 29, 2023
Under Examination
Sep 17, 2024
Approved for Publication
Jul 23, 2024
Published for Opposition
Jul 23, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Sep 17, 2025 71 days

Basic Information

Serial Number
98204247
Deadline
September 17, 2025
Description
Statement of Use or 2nd Extension Due
Filing Date
September 29, 2023
Published for Opposition
July 23, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Feb 20, 2025
Application
Pending
Classes
005

Rights Holder

Forte Bio-Pharma LLC

16
Address
8311 West Sunset Road, Suite 150
Las Vegas, NV 89113

Ownership History

Forte Bio-Pharma LLC

Original Applicant
16
Las Vegas, NV

Forte Bio-Pharma LLC

Owner at Publication
16
Las Vegas, NV

Legal Representation

Attorney
Harold Milstein

USPTO Deadlines

Next Deadline
71 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
September 17, 2025
Extension Available
Until September 17, 2025

Application History

19 events
Date Code Type Description
Feb 21, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 21, 2025 EX1G S SOU EXTENSION 1 GRANTED
Feb 20, 2025 EXT1 S SOU EXTENSION 1 FILED
Feb 20, 2025 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 17, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 23, 2024 PUBO A PUBLISHED FOR OPPOSITION
Jul 23, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 3, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 15, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 13, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 13, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED
Jun 13, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED
Jun 13, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN
May 23, 2024 GNRT F NON-FINAL ACTION E-MAILED
May 23, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 23, 2024 CNRT R NON-FINAL ACTION WRITTEN
May 21, 2024 DOCK D ASSIGNED TO EXAMINER
Oct 12, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 3, 2023 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for treatment of seizures and epilepsy; pharmaceutical products and substances for the treatment of central nervous system diseases; anti-convulsant

Classification

International Classes
005